Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-12-16
2009-08-18
Shiao, Rei-Tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S371000, C514S377000, C548S139000, C548S195000, C548S233000
Reexamination Certificate
active
07576108
ABSTRACT:
According to the present invention there is provided a compounds of formula (I): and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: WO 01/36415 (2001-05-01), None
patent: WO 0136415 (2001-05-01), None
patent: WO 01/83465 (2001-11-01), None
patent: WO 01/85706 (2001-11-01), None
patent: WO 01/85707 (2001-11-01), None
Barrett David Gene
Heuser Stefan
Riedl Rainer
Tebbe Mark Joseph
Weichert Andreas Gerhard
Eli Lilly and Company
Kosack Joseph R
Myers James B.
Shiao Rei-Tsang
LandOfFree
Substituted arylcyclopropylacetamides as glucokinase activators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted arylcyclopropylacetamides as glucokinase activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted arylcyclopropylacetamides as glucokinase activators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4064191